Selected research
Industry Growth & Trends
Global Non-invasive Tumor Detection Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Non-invasive Tumor Detection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Non-invasive Tumor Detection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Non-invasive Tumor Detection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Non-invasive Tumor Detection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Non-invasive Tumor Detection market include Datar Cancer Genetics, Nucleix, bioAffinity Technologies, miR Scientific, Nonacus, Natera and Penn Medicine, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Non-invasive Tumor Detection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Non-invasive Tumor Detection market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Non-invasive Tumor Detection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Non-invasive Tumor Detection.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Non-invasive Tumor Detection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Non-invasive Tumor Detection Market by Company
Datar Cancer Genetics
Nucleix
bioAffinity Technologies
miR Scientific
Nonacus
Natera
Penn Medicine
Non-invasive Tumor Detection Segment by Type
DNA
RNA
Non-invasive Tumor Detection Segment by Application
Prostate Cancer
Bladder Cancer
Pancreatic Cancer
Breast Cancer
Gastric Cancer
Others
Non-invasive Tumor Detection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-invasive Tumor Detection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Non-invasive Tumor Detection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-invasive Tumor Detection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Non-invasive Tumor Detection companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- DNA
- RNA
Applications
- Prostate Cancer
- Bladder Cancer
- Pancreatic Cancer
- Breast Cancer
- Gastric Cancer
- Others
Companies covered
- Datar Cancer Genetics
- Nucleix
- bioAffinity Technologies
- miR Scientific
- Nonacus
- Natera
- Penn Medicine
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Non-invasive Tumor Detection Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Non-invasive Tumor Detection Market Size by Region (2021-2032)
- 1.4.1 Global Non-invasive Tumor Detection Market Size by Region (2021-2026)
- 1.4.2 Global Non-invasive Tumor Detection Market Size by Region (2027-2032)
- 1.5 Key Regions Non-invasive Tumor Detection Market Size (2021-2032)
- 1.5.1 North America Non-invasive Tumor Detection Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Non-invasive Tumor Detection Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Non-invasive Tumor Detection Market Size Growth Rate (2021-2032)
- 1.5.4 South America Non-invasive Tumor Detection Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Non-invasive Tumor Detection Market Size Growth Rate (2021-2032)
2 Non-invasive Tumor Detection Market by Type
- 2.1 Type Introduction
- 2.1.1 DNA
- 2.1.2 RNA
- 2.2 Global Non-invasive Tumor Detection Market Size by Type
- 2.2.1 Global Non-invasive Tumor Detection Market Size Overview by Type (2021-2032)
- 2.2.2 Global Non-invasive Tumor Detection Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Non-invasive Tumor Detection Market Size Forecasted by Type (2027-2032)
- 2.3 Global Non-invasive Tumor Detection Market Size by Regions
- 2.3.1 North America Non-invasive Tumor Detection Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Non-invasive Tumor Detection Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Non-invasive Tumor Detection Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Non-invasive Tumor Detection Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Non-invasive Tumor Detection Market Size Breakdown by Type (2021-2026)
3 Non-invasive Tumor Detection Market by Application
- 3.1 Type Introduction
- 3.1.1 Prostate Cancer
- 3.1.2 Bladder Cancer
- 3.1.3 Pancreatic Cancer
- 3.1.4 Breast Cancer
- 3.1.5 Gastric Cancer
- 3.1.6 Others
- 3.2 Global Non-invasive Tumor Detection Market Size by Application
- 3.2.1 Global Non-invasive Tumor Detection Market Size Overview by Application (2021-2032)
- 3.2.2 Global Non-invasive Tumor Detection Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Non-invasive Tumor Detection Market Size Forecasted by Application (2027-2032)
- 3.3 Global Non-invasive Tumor Detection Market Size by Regions
- 3.3.1 North America Non-invasive Tumor Detection Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Non-invasive Tumor Detection Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Non-invasive Tumor Detection Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Non-invasive Tumor Detection Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Non-invasive Tumor Detection Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Non-invasive Tumor Detection Industry Trends
- 4.2 Non-invasive Tumor Detection Industry Drivers
- 4.3 Non-invasive Tumor Detection Industry Opportunities and Challenges
- 4.4 Non-invasive Tumor Detection Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Non-invasive Tumor Detection Revenue (2021-2026)
- 5.2 Global Non-invasive Tumor Detection Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Non-invasive Tumor Detection Key Company Headquarters & Area Served
- 5.4 Global Non-invasive Tumor Detection Company, Product Type & Application
- 5.5 Global Non-invasive Tumor Detection Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Non-invasive Tumor Detection Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Non-invasive Tumor Detection Players Market Share by Revenue in 2025
- 5.6.3 2025 Non-invasive Tumor Detection Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Datar Cancer Genetics
- 6.1.1 Datar Cancer Genetics Company Information
- 6.1.2 Datar Cancer Genetics Business Overview
- 6.1.3 Datar Cancer Genetics Non-invasive Tumor Detection Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Datar Cancer Genetics Non-invasive Tumor Detection Product Portfolio
- 6.1.5 Datar Cancer Genetics Recent Developments
- 6.2 Nucleix
- 6.2.1 Nucleix Company Information
- 6.2.2 Nucleix Business Overview
- 6.2.3 Nucleix Non-invasive Tumor Detection Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Nucleix Non-invasive Tumor Detection Product Portfolio
- 6.2.5 Nucleix Recent Developments
- 6.3 bioAffinity Technologies
- 6.3.1 bioAffinity Technologies Company Information
- 6.3.2 bioAffinity Technologies Business Overview
- 6.3.3 bioAffinity Technologies Non-invasive Tumor Detection Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 bioAffinity Technologies Non-invasive Tumor Detection Product Portfolio
- 6.3.5 bioAffinity Technologies Recent Developments
- 6.4 miR Scientific
- 6.4.1 miR Scientific Company Information
- 6.4.2 miR Scientific Business Overview
- 6.4.3 miR Scientific Non-invasive Tumor Detection Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 miR Scientific Non-invasive Tumor Detection Product Portfolio
- 6.4.5 miR Scientific Recent Developments
- 6.5 Nonacus
- 6.5.1 Nonacus Company Information
- 6.5.2 Nonacus Business Overview
- 6.5.3 Nonacus Non-invasive Tumor Detection Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Nonacus Non-invasive Tumor Detection Product Portfolio
- 6.5.5 Nonacus Recent Developments
- 6.6 Natera
- 6.6.1 Natera Company Information
- 6.6.2 Natera Business Overview
- 6.6.3 Natera Non-invasive Tumor Detection Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Natera Non-invasive Tumor Detection Product Portfolio
- 6.6.5 Natera Recent Developments
- 6.7 Penn Medicine
- 6.7.1 Penn Medicine Company Information
- 6.7.2 Penn Medicine Business Overview
- 6.7.3 Penn Medicine Non-invasive Tumor Detection Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Penn Medicine Non-invasive Tumor Detection Product Portfolio
- 6.7.5 Penn Medicine Recent Developments
7 North America
- 7.1 North America Non-invasive Tumor Detection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Non-invasive Tumor Detection Market Size by Country (2021-2026)
- 7.3 North America Non-invasive Tumor Detection Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Non-invasive Tumor Detection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Non-invasive Tumor Detection Market Size by Country (2021-2026)
- 8.3 Europe Non-invasive Tumor Detection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Non-invasive Tumor Detection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Non-invasive Tumor Detection Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Non-invasive Tumor Detection Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Non-invasive Tumor Detection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Non-invasive Tumor Detection Market Size by Country (2021-2026)
- 10.3 South America Non-invasive Tumor Detection Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Non-invasive Tumor Detection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Non-invasive Tumor Detection Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Non-invasive Tumor Detection Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst